Company Insider buys 40,000 shares – view details of $MNR transaction

Insider activity in the stock market can provide valuable insights into the sentiment and expectations of key stakeholders in a company. One recent notable insider purchase is that of See Remarks of $MNR, who acquired 40,000 shares of the company on November 26, 2025, amounting to an estimated $465,200. This transaction, as reported by Quiver Quantitative through SEC filings, represents an increase in their ownership of this class of stock by around 31.5%, bringing their total holdings to 167,030 shares of this class of $MNR stock.

Over the past six months, $MNR insiders have been active in trading the company’s stock on the open market, with a total of 11 transactions recorded. Impressively, all 11 of these transactions were purchases, signaling confidence and optimism among insiders about the company’s prospects. Notably, William Wallace McMullen made seven purchases, acquiring 533,222 shares for an estimated $7,687,635, while TOM L. WARD, the See Remarks of $MNR, completed four purchases, buying 167,030 shares for an estimated $1,965,128.

In addition to insider transactions, hedge fund activity surrounding $MNR has been closely watched, with recent moves indicating shifting sentiment among institutional investors. Noteworthy changes in institutional holdings include Kayne Anderson Capital Advisors LP adding 19,187,581 shares to their portfolio in Q3 2025, valued at an estimated $252,892,317. Conversely, some institutions like Goldman Sachs Group Inc and UBS Group AG have reduced their positions in $MNR stock, with significant share removals in the past quarter.

Analyst ratings on $MNR have also been a point of interest, with reports from Wall Street firms providing insights into the market consensus on the stock. While one firm issued a “Outperform” rating on August 25, 2025, indicating a positive outlook on $MNR, no sell ratings have been reported recently, suggesting overall bullish sentiment among analysts tracking the company.

Moreover, multiple analysts have offered price targets for $MNR in the last six months, with a median target of $20.0. These price targets reflect analysts’ expectations for the stock’s performance and valuation, with individual analysts like Tim Rezvan from Keybanc and John Freeman from Raymond James setting specific price targets based on their analysis and projections.

It is essential to note that all information presented in this article is for informational purposes only and should not be considered financial advice. For further details and disclaimers, readers are encouraged to consult with Quiver Quantitative for additional information on insider activity, hedge fund holdings, analyst ratings, and price targets related to $MNR.